Literature DB >> 20708805

First direct comparison of platelet reactivity and thrombolytic status between Japanese and Western volunteers: possible relationship to the "Japanese paradox".

Diana A Gorog1, Junichiro Yamamoto, Smriti Saraf, Hiromitsu Ishii, Yoshinobu Ijiri, Hideo Ikarugi, David M Wellsted, Mari Mori, Yukio Yamori.   

Abstract

OBJECTIVE: To determine and compare thrombotic and endogenous thrombolytic status in Japanese and Western populations.
BACKGROUND: Incidence of coronary heart disease (CHD) and AMI in Japan remains lower than in Western countries. Primary genetic effects are unlikely, given the increased CHD in Japanese migrants. For men, cholesterol and blood pressure have been similar in Japan and the U.S. Dietary factors are implicated, but how these effect CHD is unclear. We postulated that differences in thrombotic and/or thrombolytic status may contribute.
METHODS: We measured thrombotic and thrombolytic status in 100 healthy Japanese (J) from Japan and 100 healthy Westerners (W) from the U.K. using the Global Thrombosis Test (GTT). The GTT employs non-anticoagulated blood to create platelet-rich thrombi under high shear (occlusion time OT; seconds), and then measures the restart of blood flow, due to spontaneous thrombolysis (lysis time LT; seconds).
RESULTS: OT was longer in (J) compared to (W) (545 vs. 364, p<0.0001). LT was longer in (J) than in (W) (1753 vs. 1052, p<0.0001). Distribution of LT in (J) did not conform to a normal population, with markedly impaired thrombolytic status (LT>3,000 s) in 18%, compared to none of the Westerners (p<0.0001).
CONCLUSIONS: There are marked differences in thrombotic and thrombolytic status, with (J) having less prothrombotic (longer OT) but less favourable endogenous thrombolytic profile (longer LT). This may be important in the aetiology of thrombotic events. Since platelets and thrombolysis were both inhibited in (J) and yet incidence of AMI is lower, OT would seem more important than LT as a determinant of overall thrombotic risk in this population.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20708805     DOI: 10.1016/j.ijcard.2010.07.002

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  12 in total

1.  Attenuation of spontaneous thrombolytic activity measured by the global thrombosis test in male habitual smokers.

Authors:  Akira Suehiro; Ichiro Wakabayashi; Tsutomu Yamashita; Junichiro Yamamoto
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300

Review 2.  Expert consensus document: World Heart Federation expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI.

Authors:  Glenn N Levine; Young-Hoon Jeong; Shinya Goto; Jeffrey L Anderson; Yong Huo; Jessica L Mega; Kathryn Taubert; Sidney C Smith
Journal:  Nat Rev Cardiol       Date:  2014-08-26       Impact factor: 32.419

3.  JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan.

Authors:  Yoko Edahiro; Soji Morishita; Kochi Takahashi; Yumi Hironaka; Yuriko Yahata; Yoshitaka Sunami; Shuichi Shirane; Miyuki Tsutsui; Masaaki Noguchi; Michiaki Koike; Kiyotoshi Imai; Keita Kirito; Naohiro Noda; Yuji Sekiguchi; Satoshi Tsuneda; Akimichi Ohsaka; Marito Araki; Norio Komatsu
Journal:  Int J Hematol       Date:  2014-03-28       Impact factor: 2.490

4.  "East asian paradox": challenge for the current antiplatelet strategy of "one-guideline-fits-all races" in acute coronary syndrome.

Authors:  Young-Hoon Jeong
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

5.  PAR-1 antagonist vorapaxar favorably improves global thrombotic status in patients with coronary disease.

Authors:  G Rosser; P Tricoci; D Morrow; C Christopoulos; M N Niespialowska-Steuden; R Kozarski; R Wilcox; D A Gorog
Journal:  J Thromb Thrombolysis       Date:  2014-11       Impact factor: 2.300

6.  Long-term safety and efficacy of the Resolute stent: 5-year results from the RESOLUTE China Registry: RESOLUTE China Registry 5-year outcomes.

Authors:  Shubin Qiao; Lianglong Chen; Shao-Liang Chen; Weimin Wang; Beth Ferri; Minglei Liu; Guoying Zhu
Journal:  AsiaIntervention       Date:  2021-07

Review 7.  Comparison of clinical outcomes after drug-eluting stent implantation in diabetic versus nondiabetic patients in China: A retrospective study.

Authors:  Yong-Jin Jiang; Wei-Xing Han; Chao Gao; Jun Feng; Zheng-Fei Chen; Jing Zhang; Chun-Miao Luo; Jian-Yuan Pan
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

Review 8.  Prevention of thrombotic disorders by antithrombotic diet and exercise: evidence by using global thrombosis tests.

Authors:  Junichiro Yamamoto; Yoshinobu Ijiri; Hideo Ikarugi; Kazunori Otsui; Nobutaka Inoue; Kjell S Sakariassen
Journal:  Future Sci OA       Date:  2018-01-24

9.  Are all wines made from various grape varieties beneficial in the prevention of myocardial infarction and stroke?

Authors:  Masahiro Iwasaki; Masahiro Murakami; Yoshinobu Ijiri; Muneshige Shimizu; Junichiro Yamamoto
Journal:  Future Sci OA       Date:  2020-11-09

10.  Global Thrombosis Test: Occlusion Is Attributable to Shear-Induced Platelet Thrombus Formation.

Authors:  Diana A Gorog; Junichiro Yamamoto
Journal:  TH Open       Date:  2021-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.